Between 2024 and 2034, the worldwide Meningococcal Vaccine Market is forecasted to grow steadily, with a Compound Annual Growth Rate (CAGR) of 10.3%. Starting at an estimated worth of US$ 4,049.1 million in 2024, the market is anticipated to escalate, reaching a substantial value of US$ 10,788.0 million in sales by 2034.
The meningococcal vaccine industry is witnessing significant shifts...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek